Cargando…

Opportunities and Challenges for Gut Microbiota in Acute Leukemia

Acute leukemia (AL) is a highly heterogeneous hematologic malignancy, and although great progress has been made in the treatment of AL with allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and new targeted drugs, problems such as infection and GVHD in AL treatment are still serious. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Tao, Chen, Yan, Li, Li-Juan, Zhang, Lian-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293295/ https://www.ncbi.nlm.nih.gov/pubmed/34307157 http://dx.doi.org/10.3389/fonc.2021.692951

Ejemplares similares

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
por: Zhang, Wanru, et al.
Publicado: (2021)

Gut microbiota and cardiovascular disease: opportunities and challenges
por: Kazemian, Negin, et al.
Publicado: (2020)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
por: Kang, Synat, et al.
Publicado: (2022)

Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
por: Li, Bolei, et al.
Publicado: (2021)

Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
por: Li, Wenyu, et al.
Publicado: (2021)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
por: Guo, Shanshan, et al.
Publicado: (2020)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
por: Zhao, Junmei, et al.
Publicado: (2022)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy
por: Liu, Xiangjun, et al.
Publicado: (2021)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
por: Gaipl, Udo S., et al.
Publicado: (2020)

Intracranial Metastatic Disease: Present Challenges, Future Opportunities
por: Li, Alyssa Y., et al.
Publicado: (2022)

Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022)

Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
por: Zha, Cheng, et al.
Publicado: (2023)

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
por: Jin, Jing, et al.
Publicado: (2019)

In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls
por: Isenring, Julia, et al.
Publicado: (2023)

Interactions Between Gut Microbiota and Acute Childhood Leukemia
por: Wen, Yuxi, et al.
Publicado: (2019)

Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota
por: Wei, Yibing, et al.
Publicado: (2023)

Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
por: Zhang, Juan, et al.
Publicado: (2021)

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia
por: Yin, Jia, et al.
Publicado: (2021)

Opportunities and Challenges for Successful Use of Bevacizumab in Pediatrics
por: Barone, Amy, et al.
Publicado: (2013)

Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
por: Xie, Cuiying, et al.
Publicado: (2023)

Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer
por: Li, Hailong, et al.
Publicado: (2023)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
por: Han, Caixia, et al.
Publicado: (2021)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
por: Molica, Matteo, et al.
Publicado: (2021)

Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
por: Zhou, Jianfeng, et al.
Publicado: (2021)

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
por: Yang, Zhengyang, et al.
Publicado: (2022)

Altered Gut Microbiota Associated With Hemorrhage in Chronic Radiation Proctitis
por: Liu, Liangzhe, et al.
Publicado: (2021)

Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
por: Li, Jing, et al.
Publicado: (2022)

Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023)

Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities
por: Xue, Qin, et al.
Publicado: (2022)

Biotransformation of Abiraterone Into Five Characteristic Metabolites by the Rat Gut Microbiota and Liver Microsomes
por: Keranmu, Adili, et al.
Publicado: (2022)

Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
por: Qin, Hao, et al.
Publicado: (2022)

Big Data in Designing Clinical Trials: Opportunities and Challenges
por: Mayo, Charles S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jjd6htgcek8lcnlpuuir9i9mgp